Last updated on February 2020

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis


Brief description of study

The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).

Clinical Study Identifier: NCT03831191

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.